PubRank

A Tarkowski

Author PubWeight™ 207.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983 6.71
2 Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 2001 5.06
3 The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993 4.00
4 Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 1992 2.64
5 The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994 2.44
6 Experimental Staphylococcus aureus arthritis in mice. Infect Immun 1991 2.24
7 Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997 2.08
8 Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol 1988 1.83
9 The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun 1997 1.80
10 Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990 1.75
11 Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 1999 1.68
12 Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun 2000 1.65
13 Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003 1.62
14 Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 1999 1.61
15 Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995 1.58
16 Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 1999 1.52
17 Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 1997 1.51
18 Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003 1.38
19 Genistein as an anti-inflammatory agent. Inflamm Res 2003 1.35
20 Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest 1998 1.35
21 Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A 1994 1.33
22 Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur J Immunol 1994 1.32
23 The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect Immun 2001 1.30
24 The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology 1998 1.30
25 Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. J Immunol 1995 1.28
26 Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis. Arthritis Rheum 1996 1.27
27 Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol 1995 1.26
28 Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol 1990 1.26
29 Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000 1.26
30 A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens. J Immunol Methods 1986 1.25
31 Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J Immunol Methods 1984 1.21
32 Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol 1994 1.19
33 Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study. Clin Exp Immunol 1984 1.19
34 Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992 1.19
35 Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis 2006 1.18
36 Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol 1983 1.18
37 TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol 1998 1.18
38 Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect Immun 1996 1.17
39 Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology 1987 1.17
40 Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue. J Immunol 1989 1.16
41 Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis 2001 1.16
42 The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol 2007 1.16
43 Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology 1989 1.15
44 Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol 1992 1.14
45 Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int Arch Allergy Appl Immunol 1986 1.13
46 Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation 1993 1.12
47 Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man. Clin Exp Immunol 1985 1.12
48 Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T-cells and monokines. Cell Immunol 1993 1.11
49 Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 1996 1.11
50 Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol Scand 2001 1.10
51 Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis 1994 1.09
52 Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis. Arthritis Rheum 2000 1.09
53 Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun 1994 1.08
54 Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis 1999 1.08
55 Generation of monoclonal rheumatoid factors after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor. Scand J Immunol 1986 1.07
56 Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol 1983 1.07
57 Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol 1999 1.06
58 The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum 2000 1.05
59 Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis. Rheumatology (Oxford) 2004 1.05
60 Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol 1995 1.05
61 Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. J Biol Chem 1994 1.04
62 Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis 1997 1.04
63 Beneficial effect of captopril on systemic lupus erythematosus-like disease in MRL lpr/lpr mice. Int Arch Allergy Appl Immunol 1988 1.03
64 Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice. Clin Exp Immunol 1986 1.02
65 Vitamin A deficiency predisposes to Staphylococcus aureus infection. Infect Immun 1996 1.01
66 Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides 2000 1.01
67 Role of gamma/delta T cell receptor-expressing lymphocytes in cutaneous infection caused by Staphylococcus aureus. Clin Exp Immunol 2003 1.01
68 The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response. Microb Pathog 2001 1.01
69 Neutrophil mediated inflammatory response in murine lupus. Autoimmunity 1993 1.00
70 Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study. Neurology 2003 1.00
71 Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Immunology 1991 1.00
72 An experimental model of cutaneous infection induced by superantigen-producing Staphylococcus aureus. J Invest Dermatol 2000 0.99
73 Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. J Immunol 1998 0.98
74 Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy. Scand J Immunol 2007 0.98
75 In situ hybridization analysis of synovial and systemic cytokine messenger RNA expression in superantigen-mediated Staphylococcus aureus arthritis. Arthritis Rheum 1996 0.98
76 Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect Immun 1995 0.98
77 Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology 1989 0.97
78 Successful treatment of autoimmunity in MRL/1 mice with LS-2616, a new immunomodulator. Arthritis Rheum 1986 0.97
79 The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs. Arthritis Rheum 2000 0.96
80 Staphylococcal peptidoglycans induce arthritis. Arthritis Res 2001 0.96
81 Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation. Scand J Immunol 1989 0.95
82 False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents. J Immunol Methods 1983 0.95
83 Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis Rheum 1997 0.95
84 Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice. Immunology 1986 0.95
85 Progression of sialadenitis in Sjögren's syndrome. Br J Rheumatol 1993 0.94
86 Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis. Arthritis Res 2000 0.94
87 Patterns of interferon-gamma mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes. Cell Immunol 1995 0.94
88 Autoimmunity to collagen in adult periodontal disease. J Oral Pathol 1988 0.94
89 Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice. Clin Immunol Immunopathol 1987 0.93
90 Effect of captopril on murine systemic lupus erythematosus disease. J Hypertens Suppl 1988 0.92
91 Inhibition of nitric oxide synthase (NOS) aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol 1997 0.92
92 Intracisternally localized bacterial DNA containing CpG motifs induces meningitis. J Immunol 2001 0.92
93 Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res 2001 0.92
94 Origin of the autoreactive anti-type II collagen response. I. Frequency of specific and multispecific B cells in primed murine lymph nodes. Immunology 1987 0.92
95 Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis. Clin Exp Immunol 1999 0.92
96 An immunoenzyme procedure for enumerating fibronectin-secreting cells. J Immunoassay 1984 0.91
97 Involvement of macrophages and dendritic cells in synovial inflammation of collagen induced arthritis in DBA/1 mice and spontaneous arthritis in MRL/lpr mice. Autoimmunity 1991 0.91
98 Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. Mult Scler 2009 0.91
99 Protective role of sialophorin (CD43)-expressing cells in experimental Staphylococcus aureus infection. Infect Immun 1994 0.91
100 Enhancement of antigen-specific T-cell reactivity on the affected side in stroke patients. J Neuroimmunol 1991 0.90
101 Production of antibodies to gliadin in intestinal mucosa of patients with coeliac disease: a study at the single cell level. Gut 1989 0.90
102 Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis. Ann Rheum Dis 1995 0.90
103 Catecholaminergic suppression of immunocompetent cells. Immunol Today 1998 0.90
104 Oral microbial flora in Sjögren's syndrome. J Rheumatol 1999 0.89
105 Lateralization of T-lymphocyte responses in patients with stroke. Effect of sympathetic dysfunction? Stroke 1995 0.88
106 Integrin-associated protein (IAP)-deficient mice are less susceptible to developing Staphylococcus aureus-induced arthritis. Microbes Infect 1999 0.88
107 TNF-alpha mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-kappaB- and p38 MAPK-dependent. J Thromb Haemost 2006 0.88
108 Stroke induced lateralization of delayed-type hypersensitivity in the early and chronic phase of the disease: a prospective study. J Clin Lab Immunol 1995 0.88
109 CD25-expressing B-lymphocytes in rheumatic diseases. Scand J Immunol 2007 0.88
110 Serum gliadin antibodies for detection and control of childhood coeliac disease. Acta Paediatr Scand 1984 0.88
111 Participation of V beta 4(+)-, V beta 7(+)-, and V beta 11(+)-T lymphocytes in haematogenously acquired Staphylococcus aureus nephritis. Scand J Immunol 1996 0.88
112 Impact of topoisomerase II inhibition on cytokine and chemokine production. Inflamm Res 2003 0.87
113 Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann N Y Acad Sci 2000 0.87
114 Role of intercellular adhesion molecule 1 in pathogenesis of staphylococcal arthritis and in host defense against staphylococcal bacteremia. Infect Immun 1996 0.87
115 Localization of the brain lesion affects the lateralization of T-lymphocyte dependent cutaneous inflammation. Evidence for an immunoregulatory role of the right frontal cortex-putamen region. Scand J Immunol 1998 0.87
116 Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microb Pathog 2005 0.87
117 Immunohistochemical characterization of synovial cells in arthritic MRL-lpr/lpr mice. Arthritis Rheum 1987 0.87
118 Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 1999 0.86
119 Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies. Eur J Immunol 1994 0.86
120 Are B lymphocytes of importance in severe Staphylococcus aureus infections? Infect Immun 2000 0.86
121 The impact of substance P signalling on the development of experimental staphylococcal sepsis and arthritis. Scand J Immunol 2008 0.86
122 Overexpression of the T-cell receptor V beta 3 in transgenic mice increases mortality during infection by enterotoxin A-producing Staphylococcus aureus. Infect Immun 1995 0.85
123 Pathological survivin expression links viral infections with pathogenesis of erosive rheumatoid arthritis. Scand J Immunol 2007 0.85
124 T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. Ann Rheum Dis 1987 0.85
125 Local T-cell proliferation and differentiation in inflammatory myopathies. Scand J Immunol 1995 0.85
126 B-cell CD25 expression in murine primary and secondary lymphoid tissue. Scand J Immunol 2006 0.84
127 Histocompatibility complex gene products and exposure to oestrogen: two independent disease accelerating factors in murine lupus. Scand J Immunol 1993 0.84
128 Beneficial effect of glucocorticoids on the course of haematogenously acquired Staphylococcus aureus nephritis. Scand J Immunol 1997 0.84
129 Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4-deficient mice depends on the genetic background of the host. Eur J Immunol 1999 0.84
130 Expression of the mucosal lymphocyte integrin alphaEbeta7 and its ligand E-cadherin in salivary glands of patients with Sjögren's syndrome. Scand J Rheumatol 1998 0.84
131 Expression of heterozygous lpr gene in MRL mice. II. Acceleration of glomerulonephritis, sialadenitis, and autoantibody production. Scand J Immunol 1990 0.84
132 Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol 2002 0.84
133 Histamine in rheumatoid arthritis. Scand J Immunol 2007 0.83
134 Transient appearance of circulating interleukin-6 and tumor necrosis factor in germ-free C3H/HeJ and C3H/HeN mice upon intestinal exposure to E. coli. Adv Exp Med Biol 1995 0.83
135 An MTT-based method for the in vivo quantification of myotoxic activity of snake venoms and its neutralization by antibodies. J Immunol Methods 1993 0.83
136 Impact of transcription factors AP-1 and NF-kappaB on the outcome of experimental Staphylococcus aureus arthritis and sepsis. Microbes Infect 2001 0.82
137 Differential effects of oestrogen in murine lupus: acceleration of glomerulonephritis and amelioration of T cell-mediated lesions. J Autoimmun 1991 0.82
138 Lateralization of cutaneous inflammatory responses in patients with unilateral paresis after poliomyelitis. J Neuroimmunol 1996 0.82
139 Differential immunological aberrations in patients with primary and secondary Sjögren's syndrome. Scand J Immunol 1997 0.82
140 Detection of single antibody-secreting cells generated after in vitro antigen-induced stimulation of human peripheral blood lymphocytes. Scand J Immunol 1984 0.82
141 Virulence factors of Staphylococcus aureus strains causing infective endocarditis--a comparison with strains from skin infections. APMIS 1998 0.82
142 The rat antigen-presenting lectin-like receptor complex influences innate immunity and development of infectious diseases. Genes Immun 2009 0.82
143 Neutralization of the cytolytic and myotoxic activities of phospholipases A2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family. Biochem Pharmacol 1994 0.82
144 The gut as an inductive site for synovial and extra-articular immune responses in rheumatoid arthritis. Ann Rheum Dis 1994 0.82
145 Antigen-specific regulation of CD1 expression in humans. J Clin Immunol 2000 0.81
146 Increased systemic T-lymphocyte reactivity in patients with established stroke. J Clin Lab Immunol 1991 0.81
147 Solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of IgG rheumatoid factor-secreting cells. J Immunol Methods 1984 0.81
148 Role of selectins in experimental Staphylococcus aureus-induced arthritis. Eur J Immunol 2000 0.81
149 Clonal growth of human articular cartilage and the functional role of the periosteum in chondrogenesis. Osteoarthritis Cartilage 2005 0.81
150 Broad cytolytic specificity of myotoxin II, a lysine-49 phospholipase A2 of Bothrops asper snake venom. Toxicon 1994 0.81
151 Riboflavin in innate and acquired immune responses. Inflamm Res 2005 0.80
152 Local production of IgA- and IgM-rheumatoid factors in adult periodontal disease. J Clin Immunol 1989 0.80
153 Effects of cyclosporine A on plasma cells in experimental gingivitis in dogs. J Clin Periodontol 1996 0.80
154 Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome. Clin Immunol Immunopathol 1987 0.80
155 Expression of the mucosal lymphocyte integrin alpha E beta 7 and its ligand E-cadherin in the synovium of patients with rheumatoid arthritis. Scand J Immunol 1996 0.80
156 Local infusion of infliximab for the treatment of acute joint inflammation. Ann Rheum Dis 2003 0.80
157 Biological and biochemical activities of Vipera berus (European viper) venom. Toxicon 1993 0.80
158 Participation of CD1 molecules in the presentation of bacterial protein antigens in humans. Scand J Immunol 1999 0.80
159 Thrombin generation and mortality during Staphylococcus aureus sepsis. Microb Pathog 2001 0.80
160 Intra-articular immunization induces strong systemic immune response in humans. Clin Exp Immunol 1990 0.79
161 Activity of hemorrhagic metalloproteinase BaH-1 and myotoxin II from Bothrops asper snake venom on capillary endothelial cells in vitro. Toxicon 1994 0.79
162 Synovial cytokine mRNA expression during arthritis triggered by CpG motifs of bacterial DNA. Arthritis Res 2000 0.79
163 T cell receptor V-gene usage in oral lichen planus; increased frequency of T cell receptors expressing V alpha 2 and V beta 3. Clin Exp Immunol 1994 0.79
164 Major histocompatibility complex class II region confers susceptibility to Staphylococcus aureus arthritis. Scand J Immunol 1997 0.79
165 Local and systemic TCR V gene expression in advanced periodontal disease. J Clin Periodontol 1998 0.79
166 Intra-articular tissue factor/factor VII complex induces chronic arthritis. Inflamm Res 2002 0.79
167 Immunomodulating and anti-inflammatory properties of the sympatholytic compound 6-hydroxydopamine. J Neuroimmunol 1994 0.79
168 IL-10-driven immunoglobulin production by B lymphocytes from IgA-deficient individuals correlates to infection proneness. Clin Exp Immunol 1996 0.79
169 Rheological and immunological findings in dockers with vibration-induced white fingers. Int Arch Occup Environ Health 1992 0.78
170 Influence of antihypertensive treatment on renal and extrarenal lupus manifestations in MRL/l mice. Scand J Urol Nephrol Suppl 1988 0.78
171 Circulating survivin indicates severe course of juvenile idiopathic arthritis. Clin Exp Rheumatol 2008 0.78
172 Staphylococcus aureus-induced inflammation and bone destruction in experimental models of septic arthritis. J Periodontal Res 1999 0.78
173 Increased release of tumor necrosis factor-alpha and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Acta Obstet Gynecol Scand 1996 0.78
174 Connection between autoimmunity to cartilage type II collagen and rheumatoid factor production. Monogr Allergy 1987 0.77
175 Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis. Rheumatology (Oxford) 2004 0.77
176 Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis. Rheumatology (Oxford) 2007 0.77
177 Occurrence of polymeric IgA1 rheumatoid factor in the acquired immune deficiency syndrome. J Clin Immunol 1988 0.77
178 IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions. Semin Nephrol 1987 0.77
179 Effect of MaxEPA in patients with SLE. A double-blind, crossover study. Scand J Rheumatol 1990 0.77
180 Systemic immunization for the induction of IgA responses. Curr Top Microbiol Immunol 1989 0.77
181 Peripheral denervation suppresses the late phase of delayed-type hypersensitivity. Int Arch Allergy Appl Immunol 1991 0.77
182 Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist. Ann Rheum Dis 2002 0.77
183 Phenotypes of immunocompetent cells and Ia antigen expression in oral mucosa and skin of autoimmune mouse strains. Autoimmunity 1988 0.77
184 The role of bacterial DNA in septic arthritis. Int J Mol Med 2000 0.76
185 M-component with reactivity against actin associated with thrombotic thrombocytopenic purpura. Am J Med 1991 0.76
186 Intra-articular administration of polyclonal immunoglobulin G in rheumatoid arthritis. A double-blind, placebo-controlled pilot study. Scand J Rheumatol 1996 0.76
187 Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis. J Neurosci Res 2002 0.76
188 Fasting enhances mucosal antigen specific B cell responses in rheumatoid arthritis. Ann Rheum Dis 1997 0.76
189 Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis. Infect Immun 1998 0.76
190 Effect of eicosapentaenoic acid rich menhaden oil and MaxEPA on the autoimmune disease of Mrl/l mice. Int Arch Allergy Appl Immunol 1989 0.76
191 Role of superantigens in experimental arthritis. Springer Semin Immunopathol 1996 0.76
192 Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus. Ann Rheum Dis 2000 0.76
193 Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis. J Neuroimmunol 1997 0.76
194 Does peroral administration of factor VIII induce oral tolerance in patients with acquired haemophilia A? Thromb Haemost 2000 0.75
195 V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes. Immunology 1998 0.75
196 The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis. Clin Exp Immunol 1999 0.75
197 Impact of short-term therapies with biologics on prothrombotic biomarkers in rheumatoid arthritis. Clin Exp Rheumatol 2009 0.75
198 Induction of selective anergy by toxic shock syndrome toxin-1 in CD8+ T cells. Immunology 1997 0.75
199 Rheumatoid factors in psoriatic arthropathy and in Waaler-Rose negative rheumatoid arthritis. Rheumatol Int 1984 0.75
200 The effect of immunomodulating treatment on cutaneous delayed-type hypersensitivity in MRL lpr/lpr mice. APMIS 1989 0.75
201 Phospholipase A2 and inflammation. Mol Med Today 1995 0.75
202 Effects of immunomodulating treatment on autoimmune sialadenitis in MRL/Mp-lpr/lpr mice. Agents Actions 1988 0.75
203 Spontaneous temporomandibular joint arthropathy in MRL-lpr/lpr mice. J Oral Pathol 1988 0.75
204 Interaction with complement receptor 1 (CD35) leads to amelioration of sepsis-triggered mortality but aggravation of arthritis during Staphylococcus aureus infection. Scand J Immunol 1999 0.75
205 Histological and functional features of salivary glands in rheumatic patients with oral sicca symptoms. Scand J Rheumatol 1988 0.75
206 [Syndromes with severe insulin resistance. Rare conditions but their identification is important]. Lakartidningen 1995 0.75
207 Antibody feedback regulation in MRL/lpr mice. J Autoimmun 1993 0.75
208 Reversal of T-cell anergy in autoimmune (NZB x NZW)F1 mice by transfer with non-antigen specific CD4+ T cells from young, syngeneic donors. Scand J Immunol 1991 0.75
209 Experimental Sjögren's syndrome: a review. Scand J Rheumatol Suppl 1986 0.75
210 Limited T-cell receptor V gene usage in inclusion body myositis. Scand J Immunol 1996 0.75
211 Synovial class II antigen expression and immune complex formation in rheumatoid arthritis. Acta Med Scand Suppl 1987 0.75